[{"id":"11bb818d-40e6-4fec-af67-e5c9e6902773","acronym":"","url":"https://clinicaltrials.gov/study/NCT02550535","created_at":"2021-02-01T11:52:52.801Z","updated_at":"2024-07-02T16:37:06.491Z","phase":"Phase 1/2","brief_title":"A Phase I/II Study of Gene-modified WT1 TCR Therapy in MDS \u0026 AML Patients","source_id_and_acronym":"NCT02550535","lead_sponsor":"Cell Medica Ltd","biomarkers":" WT1","pipe":" | ","alterations":" HLA-A*02:01","tags":["WT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-A*02:01"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CMD-602"],"overall_status":"Completed","enrollment":" Enrollment 3","initiation":"Initiation: 09/01/2015","start_date":" 09/01/2015","primary_txt":" Primary completion: 05/01/2018","primary_completion_date":" 05/01/2018","study_txt":" Completion: 05/01/2018","study_completion_date":" 05/01/2018","last_update_posted":"2018-10-02"}]